Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer.
This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.
von der Schulenburg
J-Matthias
JM
Leibniz University Hannover, Hannover, Germany. jms@ivbl.uni-hannover.de
Prenzler
Anne
A
Schurer
Willemien
W
D000328:Adult; D000368:Aged; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000191:economics* / Q000453:epidemiology / Q000628:therapy; D003953:Diagnosis-Related Groups; D005260:Female; D005858:Germany / Q000453:epidemiology; D006291:Health Policy; D006801:Humans; D007348:Insurance, Health; D007407:Interviews as Topic; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D012042:Registries; D012051:Reimbursement Mechanisms; D012196:Review Literature as Topic